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ABSTRACT 
The new, selective and sensitive visible spectrophotometric method has been developed for the estimation of 
Esomeprazole in bulk and in pharmaceutical preparations. This method is based on the reaction with wool fast blue, in 
the presence of buffer at P
H
 1.5 to form a colored species with a λmax 590nm.  Beer’s law is obeyed in the concentration 
range of 50-250µg/ml for both the methods.  The method was extended to pharmaceutical formulations and there was 
no interference form in any common pharmaceutical excipients and diluents. The result of analysis has been validated 
statistically and by recovery studies.   
Keywords: Spectrophotometric determination Wool fast blue, Esomeprazole. 
 
Article Info: Received 02 June, 2018;   Review Completed  10 July 2018;   Accepted  12 July 2018;   Available online 15 July 2018 
Cite this article as: 
Yoganda Swamy M.M.V., New spectrophotometric determination of esomeprazole in bulk and pharmaceutical 
dosage form using wool fast blue, Journal of Drug Delivery and Therapeutics. 2018; 8(4):320-322                     
DOI: http://dx.doi.org/10.22270/jddt.v8i4.1802  
*Address for Correspondence:  
M.M.V. Yoganda Swamy, Lecturer in  chemistry, K.V.R. College, Nandigama, Dr. A.J. Pratapareddy,  HOD, Department of chemistry,  
K.V.R. College, Nandigama.  
 
 
INTRODUCTION 
Esomeprazole magnesium is a bis(5methoxy-2-[(S)-[(4-
methoxy-3, 5-dimethyl-2-pyridinyl) methyl]sulfinyl]-
1H-benzimidazole-1yl) magnesium trihydrate. 
Esomeprazole is the S-isomer of omeprazole, which is a 
mixture of the S- and R- isomers. The magnesium salt is 
a white to slightly colored crystalline powder. It contains 
3 moles of water of solvation and is slightly soluble in 
water. The stability of esomeprazole magnesium is a 
function of pH; it rapidly degrades in acidic media, but it 
has acceptable stability under alkaline conditions. At pH 
6.8 (buffer), the half-life of the magnesium salt is about 
19 hours at 25°C and about 8 hours at 37°C. Its 
molecular formula is (C17H18N3O3S) 2MgX.3H2O with 
molecular weight of 767.2 as a trihydrate and 713.1 on 
an anhydrous basis
1, 2
.   
The methods is based on the reaction of esomeprazole 
magnesium drug as a secondary  amine with wool fast 
blue, the formed complex extracted into chloroform at 
pH 1.5. The chloroform extractable layer is used to 
determine the esomeprazole magnesium 
spectrophotometrically 
3
.  
The structure of esomeprazole magnesium is shown in 
below.   
 
Esomeprazole magnesium 
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Experiment: 
All spectral measurements were made on MAPADA 
double beam UV-Visible 1600 spectrophotometer & on 
an ELICO SL 171 MINI SPEC Spectrophotometer. An 
ELICO LI-120 Digital pH meter was also used for pH 
measurements. 
METHOD 
4-9
: 
The method is based on the reaction of each drug having 
secondary or tertiary or primary amino (aliphatic) group 
with wool fast blue, the formed complex extracted into 
chloroform at pH 1.5. The absorbance of ion pair 
complex form in extractable chloroform layer is 
measured at the wavelength of maximum absorbance for 
each drug against the reagent blank and the amount of 
drug is determined from the calibration curve made 
between the absorbance and the amount of drug.  
Spectrum of Esomeprazole treated with wool fast 
blue: 
The wavelength of maximum absorbance of the 
Esomeprazole drug treated with wool fast blue solution 
is ascertained by the following procedure. 
Into a 10 ml volumetric flasks, the standard drug 
solution (1.0 mg/ml) in chloroform were transferred and 
diluted with same so as to obtain 100 µg/ml of 
Esomeprazole. 0.5 ml of Esomeprazole solution is 
transferred into a separating funnel. This solution 0.5 ml 
of wool fast blue reagent 2 ml buffer solution are added. 
Reaction mixture was shaken gently for 5 min and 
allowed to stand for 5 min so as to separate aqueous and 
chloroform layer. The chloroform layer is separated out 
and absorbance is measured in the wavelength range of 
450 to 650 nm, against the reagent blank.  
The spectrum is given in below. 
Spectrum of Esomeprazole magnesium 
 
Spectrum of Esomeprazole magnesium 
Assay Procedure: 
Various aliquots of the standard Esomeprazole solution 
ranging from 0.5-2.5 ml are transferred into a series of 
separating funnel. To each flask, 1.5 ml of wool fast blue 
solution, 2.0 ml of buffer solution and 5 ml of 
chloroform are added. Reaction mixture in each funnel is 
shaken gently for 5 min and allowed to stand for 5 min 
so as to separate aqueous and chloroform layer. The 
chloroform layer is separated out and absorbance is 
measured at 590 nm, against the reagent blank prepared 
in similar manner omitting drug solution. Calibration 
graph is obtained by plotting absorbance values against 
the concentration of Esomeprazole solution. The 
calibration curve is found to be linear over a 
concentration range of 50-250g/ml of Esomeprazole. 
The amount of Esomeprazole present in the sample is 
estimated from the calibration graph. The results are 
presented in the next page.  
 
Calibration curve of Esomeprazole magnesium 
 
Calibration curve of Esomeprazole magnesium 
Pharmaceutical formulation of Esomeprazole: 
For analysis of tablet formulation, twenty tablets of 
Esomeprazole are weighed accurately and finely 
powdered. An accurately weighed portion of powdered 
sample, equivalent to 50 mg of Esomeprazole was taken 
in a 50 ml volumetric flask containing 25 ml of 
chloroform, sonicated for 20 minutes.  
The resultant solution is filtered through Whatmann 
filter paper No. 41 into another 50 ml volumetric flask. 
The filter paper was washed several times with 
chloroform. The washings were added to the filtrate and 
the final volume was made up to the mark with 
methanol. Further sample solution is diluted and treated 
as per the procedure of the calibration curve. Amount of 
the drug present in sample was computed from 
respective calibration curve. The results are presented in 
following table. 
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Table 1: Assay of Esomeprazole magnesium 
S.No Sample 
(mg) 
*
Amount Found(mg) 
±S.D
* 
% of 
Label claim 
 
*
C.V 
 
*
tcal 
1 40 39.98±0.28 99.95 0.7161 0.1562 
2 40 39.96±0.48 99.90 1.207 0.1853 
3 40 40.02±0.43 100.05 1.0804 0.1034 
4 40 40.06±0.35 100.15 0.8928 0.3575 
*Average of five determinations 
RESULTS AND DISCUSSION 
In this method the Esomeprazole treated with wool fast 
blue dye at 1.5 pH. The resultant solution is extracted 
with chloroform. The ion pair complex is formed in 
extractable chloroform layer. The absorbance of the 
extractable ion pair complex is measured at 590 nm 
against the reagent blank (prepared in a similar manner 
devoid of drug solution).  
The calibration curve (concentration Vs absorbance) is 
linear over the range of 50-250 μg/ml of Esomeprazole.  
The values of standard deviation are low, indicates high 
accuracy and reproducibility of the method. The‘t’ 
calculated values are compared well with the theoretical 
value of 2.78 thereby indicating that the precision of the 
method.  
There is no effect of additives and excipients such as 
starch, calcium lactose and glucose in the concentrations 
of those present in general pharmaceutical preparations. 
The proposed method is found to be simple, precise, 
accurate and time saving, reproducible and can be 
conveniently adopted for routine analysis of estimation 
of Esomeprazole in bulk drugs samples and 
pharmaceutical formulations as seen from the agreement 
of the amount of Esomeprazole in the present method 
and the labeled amount of the pharmaceutical 
preparation. 
CONCLUSION 
The proposed method is found to be simple, precise, 
accurate and time saving reproducible and can be 
conveniently adopted for routine analysis of estimation 
of esomeprazole magnesium in bulk drug samples and 
pharmaceuticals formulations. 
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